Finance

Lists
Why is YARW down 8.15%?
Dive Deeper
YARW:NASDAQ
Yarrow Bioscience Inc
$18.03
-8.15%
(-1.60) 1D
Nov 13, 4:00:00 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for YARW...
Open
$19.33
High
$19.86
Low
$17.99
Mkt. cap
170.16M
Avg. vol.
162.77K
Volume
0.00
52-wk high
$44.28
52-wk low
$13.62
EPS
-$21.85
Beta
2.15
Shares outstanding
9.44M
No. of employees
7
Open
$19.33
High
$19.86
Low
$17.99
Mkt. cap
170.16M
Avg. vol.
162.77K
Volume
0.00
52-wk high
$44.28
52-wk low
$13.62
EPS
-$21.85
Beta
2.15
Shares outstanding
9.44M
No. of employees
7
News stories
From web sources and news partners
About Yarrow Bioscience Inc
CEO-
Employees7
Founded2025
HeadquartersNew Haven, Connecticut, United States
SectorHealth Care
IndustryBiotechnology
Analyst ratings
Based on 2 analysts giving stock ratings to YARW in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for YARW in the last 3 months.
Highest
Current $18.03
$60.00 (+232.78%)
Average
$50.00 (+177.32%)
Lowest
$40.00 (+121.85%)
Analyst
Recommendation
Action
Price target
Projected
Date
Faisal Khurshid
Jefferies
Buy
Initiated
$40.00
+121.9%
11/15/2026
Yatin Suneja
Guggenheim
Buy
Initiated
$60.00
+232.8%
11/06/2026
Rami Katkhuda
LifeSci Capital
Buy
Maintained
$56.00
+210.6%
08/13/2026
Julian Harrison
BTIG
Buy
Initiated
$58.00
+221.7%
08/03/2026
Stacy Ku
TD Cowen
Buy
Initiated
-
-
07/27/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
Cost of goods sold
-
-
-
Cost of revenue
-
-
-
Research and development expenses
1.25M
4.94M
5.28M
Total research and development expenses
-
-
-
Selling, general, and admin expenses
1.62M
1.76M
5.47M
Operating expense
2.86M
6.70M
10.74M
Total operating expenses
2.86M
6.70M
10.74M
Operating income
-2.86M
-6.70M
-10.74M
Other non operating income
-
-
94.00K
EBT including unusual items
-2.74M
-6.51M
-9.72M
EBT excluding unusual items
-2.74M
-6.51M
-9.72M
Income tax expense
-
-
-
Effective tax rate
-
-
-
Other operating expenses
-
-
-
Net income
-2.74M
-6.51M
-9.72M
Net profit margin
-
-
-
Earnings per share
-
-
-
Interest and investment income
117.00K
184.00K
925.00K
Interest expense
-
-
-
Net interest expenses
117.00K
184.00K
925.00K
Depreciation and amortization charges
-
-
-
EBITDA
-
-
-
Gain or loss from assets sale
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps